
Click Here for Printable Version
|
Helpful Hints for the Preparation of Select Tc-99m Radiopharmaceuticals |
|
Ø The desired number of particles for a lung perfusion study with MAA is 200,000 to 700,000 particles. Each vial contains 3.5 to 6.5 million particles, so the number of particles must be reduced by about 90 percent in order to prepare a unit dose of MAA. The easiest way to accomplish this is to add a volume of sodium chloride to reconstitute the particles (10 mL), then withdraw 90 percent of the volume (9 mL) and discard it. This leaves 350,000 to 650,000 particles remaining in the vial that may be labeled with enough Tc-99m Pertechnetate for one patient dose. A reduced number of particles is necessary for pediatric patients and patients with certain lung disorders including pulmonary hypertension. Ø MAA, following reconstitution, is a suspension of particles. Before withdrawing a dose from the vial the particles must be resuspended. The particles in a unit dose may also need to be resuspended if allowed to settle for a length of time. Ø Both Choletec and MAA have a tendency to foam when a volume of liquid is added to the vial. This can make it difficult to draw the final patient dose. To minimize foaming, try adding volume slowly and down the inside of the vial. Ø Conserve bulk pertechnetate by adding no more than 25% more than the activity you need to draw the final patient dose. For example, add no more than 38 mCi to a DTPA kit for a 30-mCi dose. Ø Maintain negative pressure when working with radioactive materials in vials. After adding volume to the vial it is important to remove an equal or greater quantity of air from the vial. When the needle is removed from the vial, the pressure inside will be the same or less than the initial pressure. If the air is not removed, the excess pressure in the vial will expel any liquid that is near the top of the vial. Of course, this would contaminate the work area with radioactivity. Ø
Always use sodium chloride that is preservative free. Preservatives
or oxidants will oxidize tin and reduce labeling. |
|
Guidelines for the Preparation of Select Tc-99m Radiopharmaceuticals
The following
table summarizes the manufacturer’s recommendation for the
preparation of Tc-99m radiopharmaceuticals that are commonly
prepared in the nuclear medicine department. |
||||||
| Product | Generic Name | Activity Limits | Volume | Storage | Expiration | Comments |
| DTPA | Pentetate | up to 500 mCi | 2-10 mL | 2-25 oC | 12 hours | Allow 15 minutes for labeling |
| MAA | Albumin Aggregated | 20-50 mCi | 2-8 mL | 2-8 oC | 6 hours | Resuspend particles before drawing dose |
| HDP | Oxidronate | up to 300 mCi | 3-6 mL | 2-25 oC | 8 hours | |
| MDP | Medronate | up to 500 mCi | 2-10 mL | 2-30 oC | 6 hours | |
| Choletec | Mebrofenin | up to 100 mCi | 1-5 mL | 15-30 oC | 18 hours | Allow 15 minutes for labeling |